[3)-alpha-D-Galp-(1->2)-[alpha-Tyvp-(1->3)]-alpha-D-Manp-(1->4)-alpha-L-Rhap-(1->]3

Term ID

CHEBI:66886

Synonyms

(-3Galalpha1-2[Tyvalpha1-3]Manalpha1-4Rhaalpha1)3
3,6-dideoxy-alpha-D-ribo-hexopyranosyl-(1->3)-[3,6-dideoxy-alpha-D-ribo-hexopyranosyl-(1->3)-[alpha-D-galactopyranosyl-(1->2)-3-O-[(2R,3R,5S,6R)-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl]-alpha-D-mannopyranosyl-(1->4)-6-deoxy-alpha-L-mannopyranosyl-(
3,6-dideoxy-alpha-D-ribo-hexopyranosyl-(1->3)-[3,6-dideoxy-alpha-D-ribo-hexopyranosyl-(1->3)-[alpha-D-galactopyranosyl-(1->2)-3-O-[(2R,3R,5S,6R)-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl]-alpha-D-mannopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->3)-a
[3)-alpha-D-Gal-(1->2)-[alpha-Tyv-(1->3)]-alpha-D-Man-(1->4)-alpha-L-Rha-(1->]3

Definition

An oligosaccharide of 12 residues, comprising three (1->3)-linked alpha-D-Gal-(1->2)-[alpha-Tyv-(1->3)]-alpha-D-Man-(1->4)-alpha-L-Rha units.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from [3)-alpha-D-Galp-(1->2)-[alpha-Tyvp-(1->3)]-alpha-D-Manp-(1->4)-alpha-L-Rhap-(1->]3

Phenotype where environments contain [3)-alpha-D-Galp-(1->2)-[alpha-Tyvp-(1->3)]-alpha-D-Manp-(1->4)-alpha-L-Rhap-(1->]3

Phenotype modified by environments containing [3)-alpha-D-Galp-(1->2)-[alpha-Tyvp-(1->3)]-alpha-D-Manp-(1->4)-alpha-L-Rhap-(1->]3

Phenotype affecting [3)-alpha-D-Galp-(1->2)-[alpha-Tyvp-(1->3)]-alpha-D-Manp-(1->4)-alpha-L-Rhap-(1->]3

Human Disease Model